19
Dec

Despite loud objections from its advisers, the FDA granted an accelerated approval to AstraZeneca’s ovarian cancer treatment, clearing an oral therapy the U.K. drugmaker believes will bring in blockbuster sales.

…read more

Source: AstraZeneca grabs a surprise early approval for its $2B cancer contender

    

0 No comments